<?xml version="1.0" encoding="UTF-8"?>
<ref id="B90-viruses-12-00526">
 <label>90.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gordon</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Tchesnokov</surname>
    <given-names>E.P.</given-names>
   </name>
   <name>
    <surname>Woolner</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Perry</surname>
    <given-names>J.K.</given-names>
   </name>
   <name>
    <surname>Feng</surname>
    <given-names>J.Y.</given-names>
   </name>
   <name>
    <surname>Porter</surname>
    <given-names>D.P.</given-names>
   </name>
   <name>
    <surname>Gotte</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency</article-title>
  <source>J. Biol. Chem.</source>
  <year>2020</year>
  <comment>in press</comment>
  <pub-id pub-id-type="doi">10.1074/jbc.AC120.013056</pub-id>
 </element-citation>
</ref>
